UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Terminated
Unique ID issued by UMIN UMIN000016112
Receipt No. R000018718
Scientific Title Effect of ezetimibe on PCSK9 concentrations in patients with type 2 diabetes and hypercholesterolemia
Date of disclosure of the study information 2017/03/01
Last modified on 2016/03/08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of ezetimibe on PCSK9 concentrations in patients with type 2 diabetes and hypercholesterolemia
Acronym Effect of ezetimibe on PCSK9 concentrations in patients with type 2 diabetes and hypercholesterolemia
Scientific Title Effect of ezetimibe on PCSK9 concentrations in patients with type 2 diabetes and hypercholesterolemia
Scientific Title:Acronym Effect of ezetimibe on PCSK9 concentrations in patients with type 2 diabetes and hypercholesterolemia
Region
Japan

Condition
Condition Dyslipidemia
Classification by specialty
Cardiology Endocrinology and Metabolism
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the infuluence of ezetimibe on PCSK9 concentrations in patients with type 2 diabetes and dyslipidemia
Basic objectives2 Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Change in PCSK9 concentration
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 ezetimibe treatment in patients with or without statin therapy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with type 2 diabetes and hypercholesterolemia with or without statin therapy
Key exclusion criteria 1) Triglyceride over 400mg/dl
2) Patients receiving insulin
3) Pregnant
4) Subjects who is allergic to ezetimibe
5) Severe liver disease
6) Serum creatinine over 2 mg/dl
7) Patients with acute myocardial infarction, unstable angina, or stroke within 3 months
8) Secondary hypercholesterolemia, familial hypercholesterolemia
9) Patients receiving ezetimibe or fibrates
10) Unsuitable patients for this study by physicians decision
Target sample size 20

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Toru Miyoshi
Organization Okayama University
Division name Cardiovascular Medicine
Zip code
Address 2-5-1, Shikata-cho, Kita-ku, Okayama
TEL 086-235-7351
Email miyoshit@cc.okayama-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Toru Miyoshi
Organization Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences
Division name Cardiovascular Medicine
Zip code
Address 2-5-1 Shikada-cho Kita-ku Okayama
TEL 086-235-7351
Homepage URL
Email miyoshit@cc.okayama-u.ac.jp

Sponsor
Institute Okayama University, Department of Cardiovascular Medicine
Institute
Department

Funding Source
Organization Okayama University, Department of Cardiovascular Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 03 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2015 Year 12 Month 01 Day
Date of IRB
Anticipated trial start date
2017 Year 03 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 01 Month 05 Day
Last modified on
2016 Year 03 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018718

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.